Role of proteoglycans in the cell proliferation and thyroid hormone secretion
蛋白多糖在细胞增殖和甲状腺激素分泌中的作用
基本信息
- 批准号:62480259
- 负责人:
- 金额:$ 4.29万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1987
- 资助国家:日本
- 起止时间:1987 至 1989
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Proteoglyean is a macromolecule consisting of glycosaminoglycan chains covalently linked with core-glycoprotein. It is important as a ground substance in cell-culture system such as chondrocytes or osteogenic cells. The synthesis is influenced by hormone in granulosa cells.However, what kind of roles the proteoglyean does play in thyroid tissue in which particular secretory process is operating remain unanswered. In the present study, we have disclosed followings;1. Proteoglycan production in thyroid cells is closely related to the cell proliferation through cAMP dependent mechanism (Shishiba Y, et al. J Biol Chem 263:1745, 1988).2. Proteoglycan was also produced in thyroid organ culture system. Chondroitin sulfate proteoglyean was secreted into medium in a fashion dependent to the dose of TSH, while heparan sulfste proteoglyean remained in the tissue. From the autoradiography of ^<35>S, the kinetics of ^<35>S grain resembled those of thyroglobulin. It was speculated that proteoglyeans … More were produced in epithelial cells, secreted into follicular space and concentrated. Proteoglyeans may function as a mechanical support for the follicular structure in thyroid tissue, as well as in ovary (Shishiba Y, et al. Progress in Thyroidology 1989, p.259, Korea).3. Apart from thyroid tissue, proteoglycan production in fibroblast culture was enhanced by IgG's of Graves' disease with pretibial myxedema. T_3 excess also favors the,synthesis of proteoglycan. The cause of pretibial myxedema is thus the accumulation of proteoglycan produced by fibroblasts stimulated by IgG's and T_3 excess. Whether the same story can be applied to the pathogenesis of malignant exophthalmos in Graves' disease is under study (Shishiba Y, et al. The Thyroid P-385, 1988).4. Proteoglyeans are the regulator of calcification in osteogenic cell culture. In early phase of culture where calcification was not observed, osteogenic cells produced large chondroitin sulfate proteoglyean, small chondroitin sulfate proteoglycan, haparan sulfate proteoglyean and hyaluronic acids. in the calcification phase of culture, the production of these proteoglycan species was decreased dramatically. 1,25(OH)_2D_3, which enhanced calcification, decreased proteoglyean production and accelerated degradation by increasing proteoglyean binding to the receptor. Thus, proteoglyeans are one of the factors to inhibit calcification by occupying the gap junction of collagen fibers. When the production of proteoglyeans is decreased either by aging or by 1,25(OH)_2D_3, calcification starts in the unoccupied gap junction. Less
蛋白质是由糖胺聚糖链与核糖蛋白共价连接而成的大分子。在软骨细胞或成骨细胞等细胞培养系统中,它是一种重要的基质。这种合成受到颗粒细胞中激素的影响。然而,蛋白水解酶在甲状腺组织中扮演着什么样的角色,这一特定的分泌过程正在进行中,目前还没有答案。在本研究中,我们揭示了以下几点:1.甲状腺细胞蛋白多糖的产生与细胞增殖密切相关(Shishiba Y,et al.生物化学263:1745,1988)在甲状腺器官培养体系中也产生了蛋白多糖。硫酸软骨素蛋白以一种依赖于TSH剂量的方式分泌到培养液中,而肝素硫酸酯蛋白仍留在组织中。从S的放射自显影来看,S颗粒的动力学与甲状腺球蛋白相似。据推测,蛋白质酵母的…更多的是在上皮细胞中产生,分泌到滤泡间隙并浓缩。Proteoglyeans可以作为甲状腺组织和卵巢中滤泡结构的机械支撑(Shishiba Y,et al.《甲状腺生物学进展1989》,第259页,韩国)。除甲状腺组织外,Graves病合并胫前粘液水肿的免疫球蛋白可促进成纤维细胞产生蛋白多糖。T_3过量也有利于蛋白多糖的合成。因此,胫前粘液水肿的原因是成纤维细胞在免疫球蛋白和T_3过量刺激下产生的蛋白多糖的积聚。同样的故事是否可以应用于Graves病的恶性突眼的发病机制正在研究中(Shishiba Y,et al.甲状腺P-385,1988)。变形杆菌是成骨细胞培养中钙化的调节者。在未观察到钙化的培养早期,成骨细胞产生大的硫酸软骨素蛋白多糖、小的硫酸软骨素蛋白多糖、硫酸乙酰肝素蛋白多糖和透明质酸。在培养的钙化阶段,这些蛋白多糖的产量急剧下降。1,25(OH)_2D_3促进钙化,通过增加蛋白凝胶与受体的结合,减少蛋白凝胶的产生,加速降解。因此,蛋白凝胶是通过占据胶原纤维缝隙连接来抑制钙化的因素之一。当蛋白凝胶的产量因老化或1,25(OH)_2D_3而减少时,钙化开始于未被占据的缝隙连接。较少
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y. Shishiba, et al.: "Proteoglycan is involved in thyroidal secretory process" 4th Asia Oceania Thyroid Association Meeting (Abst), p.259-262, 1989.
Y. Shishiba 等:“蛋白多糖参与甲状腺分泌过程”,第 4 届亚洲大洋洲甲状腺协会会议 (Abst),第 259-262 页,1989 年。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoshimasa Shishiba;Masaki Yanagishita;Vincent C.Hascall et al: Journal of Biological Chemistry. 263. 1745-1754 (1988)
Yoshimasa Shishiba;Masaki Yanagishita;Vincent C.Hascall 等:生物化学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoshimasa Shishiba,et al.: "proteoglycan is involved in thyrodal secretory process" 4th Asis Oceania Thyroid Association Meeting(Abstract). 259-262 (1989)
Yoshimasa Shishiba等:“蛋白多糖参与甲状腺分泌过程”第四届亚洲大洋洲甲状腺协会会议(摘要)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yasuhiro Takeuchi,Yoshimasa Shishiba,et al.: "1,25-dehydroxyvitamin D_3 inhibits synthesis and enhances degradation of proteoglycans in osteoblastic cells" Jaurnal of Biological Chemistry. 264. 18407-18413 (1989)
Yasuhiro Takeuchi、Yoshimasa Shishiba 等人:“1,25-脱羟基维生素 D_3 抑制成骨细胞中蛋白多糖的合成并增强其降解”《生物化学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y. Shishiba, et al.: "Characterization of proteoglycan synthesized by rat thyroid cells in culture and their response to TSH" Journal of Biological Chemistry 263:1745-1754, 1988.
Y. Shishiba 等人:“培养物中大鼠甲状腺细胞合成的蛋白多糖的特征及其对 TSH 的反应”《生物化学杂志》263:1745-1754,1988。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHISHIBA Yoshimasa其他文献
SHISHIBA Yoshimasa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHISHIBA Yoshimasa', 18)}}的其他基金
An attempt of application Myo D transfected skin fibroblasts of patients to enhance gene expression and to analyze muscle specific Na channel proteins.
尝试应用Myo D转染患者的皮肤成纤维细胞来增强基因表达并分析肌肉特异性Na通道蛋白。
- 批准号:
07457129 - 财政年份:1995
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Investigating the effects of xyloside and TD874 on chondroitin sulfate proteoglycan levels and motor recovery in spinal cord injured rats
研究木糖苷和 TD874 对脊髓损伤大鼠硫酸软骨素蛋白聚糖水平和运动恢复的影响
- 批准号:
488145 - 财政年份:2022
- 资助金额:
$ 4.29万 - 项目类别:
Studentship Programs
Understanding the role of chondroitin sulfate proteoglycan 4-sulfation in the heart following myocardial infarction
了解硫酸软骨素蛋白多糖 4-硫酸化在心肌梗塞后心脏中的作用
- 批准号:
10186468 - 财政年份:2020
- 资助金额:
$ 4.29万 - 项目类别:
Investigating the role of chondroitin sulfate proteoglycan in neural stem cell regulation
研究硫酸软骨素蛋白多糖在神经干细胞调节中的作用
- 批准号:
524873-2018 - 财政年份:2018
- 资助金额:
$ 4.29万 - 项目类别:
University Undergraduate Student Research Awards
Melanoma-associated chondroitin sulfate proteoglycan (MCSP) as target antigen for specific immunotherapy; from the bench to the bed-side.
黑色素瘤相关硫酸软骨素蛋白多糖(MCSP)作为特异性免疫治疗的靶抗原;
- 批准号:
389786392 - 财政年份:2017
- 资助金额:
$ 4.29万 - 项目类别:
Research Grants
Analysis of DACS, novel matrix structure composed of chondroitin sulfate proteoglycan in the brain
DACS 分析,大脑中由硫酸软骨素蛋白多糖组成的新型基质结构
- 批准号:
24592141 - 财政年份:2012
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting invasiveness-inducing Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP) as a new target antigen for specific immunotherapy
将侵袭性诱导的黑色素瘤相关硫酸软骨素蛋白多糖(MCSP)作为特异性免疫治疗的新靶抗原
- 批准号:
231258884 - 财政年份:2012
- 资助金额:
$ 4.29万 - 项目类别:
Research Grants
Roles of chondroitin sulfate proteoglycan in maintenance of tissue structure and its remodeling under pathological conditions
硫酸软骨素蛋白多糖在病理条件下维持组织结构及其重塑中的作用
- 批准号:
22390077 - 财政年份:2010
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Chondroitin Sulfate Proteoglycan and Myelination in Intraventricular Hemorrhage
硫酸软骨素蛋白多糖与脑室内出血中的髓鞘形成
- 批准号:
7708744 - 财政年份:2009
- 资助金额:
$ 4.29万 - 项目类别:
Chondroitin Sulfate Proteoglycan and Myelination in Intraventricular Hemorrhage
硫酸软骨素蛋白多糖与脑室内出血中的髓鞘形成
- 批准号:
7923921 - 财政年份:2009
- 资助金额:
$ 4.29万 - 项目类别:
Neuroglycan C, a chondroitin sulfate proteoglycan, overcomes the abnormal behavior induced by administration of some drugs?
Neuroglycan C,一种硫酸软骨素蛋白多糖,可以克服某些药物引起的异常行为?
- 批准号:
21590606 - 财政年份:2009
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)